Everolimus-eluting stents in interventional cardiology

olimus-eluting stents in interventional cardiology Review (26022) Total Article Views Authors: Townsend JC, Rideout P, Steinberg DH Published Date June 2012 Volume 2012:8 Pages 393 - 405 DOI: http://dx.doi.org/10.2147/VHRM.S23388 Received: 28 January 2012 Accepted: 21 March 2012 Published: 27 June 2012 Jacob C Townsend, Phillip Rideout, Daniel H Steinberg Division of Cardiology, Medical University of South Carolina, Charleston, SC, USA Abstract: Bare metal stents have a proven safety record, but limited long-term efficacy due to in-stent restenosis. First-generation drug-eluting stents successfully countered the restenosis rate, but were hampered by concerns about their long-term safety. Second generation drug-eluting stents have combined the low restenosis rate of the first generation with improved long-term safety. We review the evolution of drug-eluting stents with a focus on the safety, efficacy, and unique characteristics of everolimus-eluting stents.